Skip to main content
. 2012 Oct 17;2012:640835. doi: 10.1155/2012/640835

Figure 2.

Figure 2

Anti-GP2 antibody titres in 225 patients with Crohn's disease (CD) stratified in two groups: patients with restricted colonic location (L2) and patients with ileal (ileal or ileocolonic) location (L1 and L3), according to Montreal classification.